2017
DOI: 10.1007/s10620-017-4567-1
|View full text |Cite
|
Sign up to set email alerts
|

Role of MiRNAs in Inflammatory Bowel Disease

Abstract: Inflammatory bowel diseases (IBD), mainly including Crohn's disease and ulcerative colitis, are characterized by chronic inflammation of the gastrointestinal tract. Despite improvements in detection, drug treatment and surgery, the pathogenesis of IBD has not been clarified. A number of miRNAs have been found to be involved in the initiation, development and progression of IBD, and they may have the potential to be used as biomarkers and therapeutic targets. Here, we have summarized the recent advances about t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
41
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 47 publications
(41 citation statements)
references
References 117 publications
0
41
0
Order By: Relevance
“…For further detail about miRNAs, both mammalian enteritis related and novel miRNAs have been found. The current miRNA results contain the IBD related miRNAs, such as miR-10, which could down-regulate mucosal inflammatory response in DC, and miR-132, which was revealed to enhance the cholinergic anti-inflammatory pathway via regulation on AchE (acetylcholinesterase) (Cao et al, 2017 ). This also predicted the inhibiting role of novel 280 and novel 179 on CD276, which may suggest their therapeutic potential.…”
Section: Discussionmentioning
confidence: 99%
“…For further detail about miRNAs, both mammalian enteritis related and novel miRNAs have been found. The current miRNA results contain the IBD related miRNAs, such as miR-10, which could down-regulate mucosal inflammatory response in DC, and miR-132, which was revealed to enhance the cholinergic anti-inflammatory pathway via regulation on AchE (acetylcholinesterase) (Cao et al, 2017 ). This also predicted the inhibiting role of novel 280 and novel 179 on CD276, which may suggest their therapeutic potential.…”
Section: Discussionmentioning
confidence: 99%
“…Although the pathogenesis of CD is still unclear, accumulating evidence shows that environmental factors, genetics, autoimmunity, and dietary habits may contribute to its development and progression[ 24 , 25 ]. As an important genetic factor, miRNA dysregulation is involved in the aetiological mechanism of several autoimmune diseases, including CD[ 26 ]; however, the role of miR-125a/b expression in CD risk and management is largely unstudied[ 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hence, miRNAs hold great promise as potential non-invasive diagnostic markers. miRNAs are dysregulated in IBD 64. Therefore, researchers have attempted to demonstrate the diagnostic value of circulating miRNAs signatures in the blood as diagnostic biomarkers using machine learning modelling, including random forests and SVM 65 66…”
Section: Current Paradigm Of Ibd Disease Management and Its Limitationsmentioning
confidence: 99%